Family Care Hospitals Limited (516110) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Family Care Hospitals Limited stock ₹0.36, price ₹1.97, that is 81.7% below the price, quality 38 out of 100. Rating: strongly overvalued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range ₹1.73 – ₹53.00 · fair‑value band ₹0.2400 – ₹0.4500 · the ₹1.97 price screens above the ₹0.3600 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Family Care Hospitals in your weekly email
Every Wednesday you see whether Family Care Hospitals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Family Care Hospitals Limited (516110) currently trades at ₹1.97, while our model-based Fair Value estimate is ₹0.3600, 82% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.
Scenario range: ₹0.2400 (bear) to ₹0.4500 (bull), the price of ₹1.97 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Health Care sector.
Mixed Growth: Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Family Care Hospitals Limited reported revenue of ₹2.1M in FY2026 versus ₹421M in FY2022, a compound −73.4%/yr. Reported net income was −₹86.8M in FY2026.
Key figures
Market cap ₹316M (≈ $3.4M) Micro · P/E ratio 23.6 · EPS (TTM) ₹0.4181 · Return on assets (EBIT) 17.6% (5-year average) · Free cash flow −₹60.4M · Net debt ₹49.0M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).
What moves the price
The share trades about 51% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Health Care peers we cover trades at −49% fair-value upside, at −82%, 516110 screens richer than that median.
Fair Value models
Bear₹0.2400Fair Value ₹0.3600Bull₹0.4500
Price ₹1.97 · Downside -81.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (₹0.2554 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.55/100
Spin-off in 2025: revenue and profit before it include the divested business. Growth is measured afresh from 2025.
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
19.0% (2021) → −1,385.1% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Compare Family Care Hospitals Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Hospitals” was too small, so the broader sector is used.)Health Care · 2276 stocks
Beats the sector median on 1/6 measures
Overall it trails its sector peers.
Valuation
Quality Score38 · Bottom 25%
Fair Value upside−81.7% · Bottom 25%
Profitability
Return on assets−20.2% · Bottom 25%
Operating margin (12 months)0.0% · Below median
Growth and dividend
Revenue growth (quarter YoY)0.0% · Below median
Valuation Multiplesvs Health Care median · lower = cheaper
P/E (12 months)23.6× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 5
FUTURE (revenue growth)0· sector 31
PAST (return on equity)0· sector 18
HEALTH (low debt)100· sector 96
DIVIDEND (yield)0· sector 33
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Family Care Hospitals Limited Fair Value". https://www.fairvalue-calculator.com/stock/516110
Frequently asked questions
Is Family Care Hospitals Limited (516110) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of ₹0.3600 versus a price of ₹1.97, about 82% lower (overvalued).
What is the fair value of 516110?
Our model-based fair value for Family Care Hospitals Limited is ₹0.3600 (as of Nov 8, 2026), built from audited fundamentals. The current price: ₹1.97.
What is the quality score of 516110?
Family Care Hospitals Limited has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Family Care Hospitals Limited (516110)?
Our model-based price target is the fair value of ₹0.3600 (as of Nov 8, 2026) from 1 valuation models. Cautious scenario ₹0.2400, optimistic scenario ₹0.4500. It is a calculation from audited fundamentals, not an analyst target.
What is the Family Care Hospitals Limited stock forecast for 2026?
Our models put fair value at ₹0.3600, about 82% lower versus a price of ₹1.97 (overvalued). Cautious scenario ₹0.2400, optimistic scenario ₹0.4500. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Family Care Hospitals Limited (516110)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Family Care Hospitals Limited it is ₹0.3600 per share (as of Nov 8, 2026), against a price of ₹1.97. It is the blended result of 1 valuation models in 1 family (Asset-Based).
Is Family Care Hospitals Limited stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 516110 trades above its calculated fair value: price ₹1.97, fair value ₹0.3600, a gap of about −82% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 516110?
No. The price is what the market pays today (₹1.97); the fair value is what the company's own numbers justify (₹0.3600). For Family Care Hospitals Limited the two are ₹1.61 per share apart. That gap is exactly why we show both numbers side by side.
How much is Family Care Hospitals Limited worth?
The market values Family Care Hospitals Limited at about ₹316M (market capitalisation, as of Nov 8, 2026). Per share that is ₹1.97; our models calculate a fair value of ₹0.3600 per share.
What do the bullish and bearish scenarios say about 516110?
Our models span a range for Family Care Hospitals Limited: cautious scenario ₹0.2400, base ₹0.3600, optimistic ₹0.4500 per share (as of Nov 8, 2026, price ₹1.97). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 516110?
Family Care Hospitals Limited trades at a price-to-earnings ratio of 23.6 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹0.3600 is built from several models across several years. Median P/E at fiscal year-end, 7 fiscal years (2017 to 2024), reported earnings: 12.2.
How far is 516110 from its 52-week high?
Family Care Hospitals Limited trades at ₹1.97, about 51% below its 52-week high of ₹4.04 and 14% above the low of ₹1.73 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ₹0.3600 is for.
Which stocks are comparable to Family Care Hospitals Limited?
From the same area (Health Care) we also value KMCSHIL, PINC, SHUKRAPHAR, TITANBIO, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Family Care Hospitals Limited stock attractive at the current price?
The data as of Nov 8, 2026: price ₹1.97, calculated fair value ₹0.3600 (−82%), Quality Score 38/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 516110 calculated?
We run Family Care Hospitals Limited through 1 models from 1 family: Asset-Based. Every model gets the same audited fundamentals; the fair value of ₹0.3600 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Family Care Hospitals Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Family Care Hospitals Limited (516110)?
The closing price on Nov 6, 2026 was ₹1.97. Our model-based fair value is ₹0.3600, about 82% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Family Care Hospitals Limited right now?
The price sits above even our optimistic bull case (₹0.4500). The favourable scenario is already priced in. Weak quality (38/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (₹0.2400 to ₹0.4500) leaves room in how you read the outcome.
Key figures of Family Care Hospitals Limited
How large is the market capitalisation of Family Care Hospitals Limited (516110)?
The market capitalisation of Family Care Hospitals Limited is ₹316M (≈ $3.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Family Care Hospitals Limited (516110)?
Earnings per share at Family Care Hospitals Limited are ₹0.4181 (price ÷ EPS = P/E 23.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the EBIT return on assets of Family Care Hospitals Limited (516110)?
On an EBIT basis the return on assets of Family Care Hospitals Limited is 17.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does Family Care Hospitals Limited (516110) generate?
The free cash flow of Family Care Hospitals Limited is −₹60.4M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Family Care Hospitals Limited (516110) carry?
The net debt of Family Care Hospitals Limited is ₹49.0M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Family Care Hospitals Limited in the live analysis
One click puts Family Care Hospitals Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
